Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh artery study

European Heart Journal

Volumn 21, Issue 19, 2000, Pages 1607-1613

  Smith, Felicity B ^a   Fowkes, F G R ^a   Rumley, A ^b   Lee, A J ^a   Lowe, G D O ^b   Hau, C M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Angina pectoris; Cardiovascular events; Leucocyte elastase; Tissue plasminogen activator

Indexed keywords

LEUKOCYTE ELASTASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FIBRINOLYSIS; GREAT BRITAIN; HUMANS; INCIDENCE; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; URBAN POPULATION;

EID: 0033794893     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2127     Document Type: Article

References (33)

1. Angina pectoris and disease progression
2. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris
3. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
4. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
5. Fibrinogen is a predictor of mortality in coronary heart disease patients
6. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up
7. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol: Results from the Angina Prognosis Study in Stockholm
8. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris
9. Fibrinolytic factors and risk of myocardial infarction or sudden death in patients with angina pectoris
10. Increased plasma viscosity and erythrocyte aggregation: Indicators of an unfavourable clinical outcome in patients with unstable angina pectoris
11. Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina
12. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population
13. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
14. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina
15. Neutrophil activation in pregnancy-induced hypertension
16. International diagnostic criteria for acute myocardial infarction and acute stroke
17. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population
18. Role of insulin resistance in human disease
19. Coronary heart disease: Overview
20. Oxygen metabolites and vasomotor mechanisms in rat cremasteric arterioles
21. Blood rheology and arterial disease
22. Thrombosis and inflammation as multicellular processes: Pathophysiologic significance of transcellular metabolism
23. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
24. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
25. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
26. Randomized controlled trial of antioxidants in intermittent claudication
27. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease
28. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI III Trial)
29. Von Willebrand factor: A marker of endothelial damage?
30. Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease
31. Haemorrheological abnormalities in unstable angina pectoris: A relation independent of risk factor profile and angiographic severity
32. Increased plasma viscosity and erythrocyte aggregation: Indicators of an unfavourable clinical outcome in patients with unstable angina pectoris